ASCO® 2024 Lung Cancer Highlights: Top Abstracts Including BEAT-SC, …

2024 ASCO® Annual Meeting Insights Hub

B. Halmos

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

Photodynamic Therapy for Malignant Airway Disease

Fayez Kheir

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

ecancer

L. Raez

Respiratory Tract, EBUS, Molecular Biomarker Testing in Non-Small Ce…

Houston Methodist

S. Roy-Chowdhuri

ASCO® 2024 Insights: "LIBRETTO-432 Trial - Adjuvant Selpercatinib vs…

2024 ASCO® Annual Meeting Insights Hub

J. Goldman

ASCO® 2023 Insights: "ADAURA Trial Key Learnings & Clinical Implicat…

Insights from 2023 ASCO® Annual Meeting

J. West

Molecular Testing on EBUS-TBNA Specimen

Cleveland Clinic Hospital Based Care Institute

A. C. Mehta

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 ASCO® …

Total Health

J. Bauman

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Total Health

W. Iams

Novel Early Management of Lung Cancer

Wenhua Liang

Role of Small Molecules in the Perioperative Setting for NSCLC

Angel Qin

ELCC 2024 Insights: "Treatment Landscape for Stages I-III NSCLC in t…

Insights from ELCC 2024

J. Donington

ASCO® 2023 Summary: "Expert Discussion on New Treatment Options for …

Insights from 2023 ASCO® Annual Meeting

D. Carbone, B. Stiles

Diagnosis and Staging of Lung Cancer in the Era of Advanced Diagnost…

Cleveland Clinic Respiratory Institute

F. Almeida

NSCLC Highlights - Best of ASCO® 2023 Meeting

Total Health

M. Das

Key Points From the ADAURA Trial: Osimertinib in NSCLC

GRACE

J. Reuss

How Does PD-L1 Score Affect Treatment Options for NSCLC

GRACE

S. Patel, T. Leal, P. Iyengar, A. Desai, C. Kim, J. Rotow

ASCO® 2023 Insights: "Dr. Roy Herbst on ADAURA Trial OS Analysis of …

ecancer

R. Herbst

ESMO 2023 Insights: "The Impact of PET-CT Brain MRI for Metastasis D…

Insights from 2023 ESMO Annual Meeting

W. Liang